Literature DB >> 8650199

Modulation of growth factor receptor function by isoform heterodimerization.

W P Chang1, C V Clevenger.   

Abstract

Activation of prolactin (PRL)-dependent signaling occurs as the result of ligand-induced dimerization of receptor (PRLr). Although three PRLr isoforms (short, intermediate, and long) have been characterized and are variably coexpressed in PRL-responsive tissues, the functional effects of ligand-induced PRLr isoform heterodimerization have not been examined. To determine whether heterodimeric PRLr complexes were capable of ligand-induced signaling and cellular proliferation, chimeras consisting of the extracellular domain of either the alpha or beta subunit of human granulocyte-macrophage colony-stimulating factor receptor (GM-CSFr) and the intracellular domain of the rat intermediate or short PRLr isoforms (PRLr-I or PRLr-S) were synthesized. Because high affinity binding of GM-CSF is mediated by the extracellular domain of one alpha and beta GM-CSFr pair, use of GM-CSFr/PRLr chimera specifically directed the dimerization of the PRLr intracellular domains within ligand-receptor complexes. Stable transfection of these constructs into the Ba/F3 line was demonstrated by Northern blot and immunoprecipitation analyses. Flow cytometry revealed specific binding of a phycoerythrin-conjugated human GM-CSF to the transfectants, confirming cell surface expression of the chimeric receptors. When tested for their ability to proliferate in response to GM-CSF, only chimeric transfectants expressing GM-CSFr/PRLr-I homodimers demonstrated significant [3H]thymidine incorporation. GM-CSF stimulation of transfectants expressing either GM-CSFr/PRLr-S homodimers or GM-CSFr/PRLr-S+1 heterodimers failed to induce proliferation. Consistent with these data, the GM-CSF-induced activation of two phosphotyrosine kinases, Jak2 and Fyn, was observed only in homodimeric GM-CSFr/PRLr-I transfectants. These results show that the PRLr-S functions as a dominant negative isoform, down-regulating both signaling and proliferation mediated by the receptor complex. Thus, structural motifs necessary for Jak2 and Fyn activation within the carboxy terminus of the PRLr-I, absent in the PRLr-S, are required in each member of the dimeric PRLr complex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8650199      PMCID: PMC39168          DOI: 10.1073/pnas.93.12.5947

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein.

Authors:  L I Zon; J F Moreau; J W Koo; B Mathey-Prevot; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

Review 2.  Prolactin as a second messenger for interleukin 2.

Authors:  M B Prystowsky; C V Clevenger
Journal:  Immunomethods       Date:  1994-08

3.  The extended box 2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells.

Authors:  T C He; N Jiang; H Zhuang; D E Quelle; D M Wojchowski
Journal:  J Biol Chem       Date:  1994-07-15       Impact factor: 5.157

Review 4.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

5.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.

Authors:  B A Witthuhn; F W Quelle; O Silvennoinen; T Yi; B Tang; O Miura; J N Ihle
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

6.  Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors.

Authors:  O Miura; J L Cleveland; J N Ihle
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

7.  A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription.

Authors:  J J Lebrun; S Ali; V Goffin; A Ullrich; P A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

Review 8.  Cytokine receptor signalling.

Authors:  J N Ihle
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

9.  Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling.

Authors:  N Sato; K Sakamaki; N Terada; K Arai; A Miyajima
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

10.  Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphoid cells.

Authors:  I Dusanter-Fourt; O Muller; A Ziemiecki; P Mayeux; B Drucker; J Djiane; A Wilks; A G Harpur; S Fischer; S Gisselbrecht
Journal:  EMBO J       Date:  1994-06-01       Impact factor: 11.598

View more
  10 in total

Review 1.  Paradigm-shifters: phosphorylated prolactin and short prolactin receptors.

Authors:  KuangTzu Huang; Eric Ueda; YenHao Chen; Ameae M Walker
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

2.  Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor.

Authors:  Y Sangeeta Devi; Aurora Shehu; Carlos Stocco; Julia Halperin; Jamie Le; Anita M Seibold; Michal Lahav; Nadine Binart; Geula Gibori
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

3.  Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function.

Authors:  Jamie A Le; Heather M Wilson; Aurora Shehu; Jifang Mao; Y Sangeeta Devi; Julia Halperin; Tetley Aguilar; Anita Seibold; Evelyn Maizels; Geula Gibori
Journal:  Biol Reprod       Date:  2012-03-22       Impact factor: 4.285

4.  A novel and functional interaction between cyclophilin A and prolactin receptor.

Authors:  Farhat Syed; Michael A Rycyzyn; Liz Westgate; Charles V Clevenger
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

5.  Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras.

Authors:  W P Chang; Y Ye; C V Clevenger
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

Review 6.  Breast Cancer and Prolactin - New Mechanisms and Models.

Authors:  Charles V Clevenger; Hallgeir Rui
Journal:  Endocrinology       Date:  2022-10-01       Impact factor: 5.051

7.  Impact of heat stress on prolactin-mediated ovarian JAK-STAT signaling in postpubertal gilts.

Authors:  Crystal M Roach; Katie L Bidne; Matthew R Romoser; Jason W Ross; Lance H Baumgard; Aileen F Keating
Journal:  J Anim Sci       Date:  2022-07-01       Impact factor: 3.338

8.  The human intermediate prolactin receptor is a mammary proto-oncogene.

Authors:  Jacqueline M Grible; Patricija Zot; Amy L Olex; Shannon E Hedrick; J Chuck Harrell; Alicia E Woock; Michael O Idowu; Charles V Clevenger
Journal:  NPJ Breast Cancer       Date:  2021-03-26

9.  The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.

Authors:  Huizhen Nie; Pei-Qi Huang; Shu-Heng Jiang; Qin Yang; Li-Peng Hu; Xiao-Mei Yang; Jun Li; Ya-Hui Wang; Qing Li; Yi-Fan Zhang; Lei Zhu; Yan-Li Zhang; Yanqiu Yu; Gary Guishan Xiao; Yong-Wei Sun; Jianguang Ji; Zhi-Gang Zhang
Journal:  Theranostics       Date:  2021-02-06       Impact factor: 11.556

10.  Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer.

Authors:  Noboru Harada; Akihiko Himeno; Kazuto Shigematsu; Kohji Sumikawa; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2002-04       Impact factor: 5.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.